On December 12, 2023, Craig S. Gilgallon, General Counsel, informed Cingulate Inc. that he was resigning as an officer of the company and was terminating employment with Cingulate Therapeutics LLC effective on December 15, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 USD | -2.73% | -1.38% | -89.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.80% | 4.85M | |
+35.72% | 50.93B | |
-0.15% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.54% | 26.02B | |
-22.55% | 18.9B | |
+7.54% | 13.21B | |
+24.70% | 12.17B | |
+29.29% | 12.16B |
- Stock Market
- Equities
- CING Stock
- News Cingulate Inc.
- Cingulate Inc. and Cingulate Therapeutics LLC Announce Resignation of Officer